Studies have demonstrated that in human umbilical vein endothelial cells, METTL3 and METTL14 can upregulate p65 expression, leading to decreased levels of BCL-2 and exacerbated atherosclerosis [248]. This evidence concerns the gene METTL14 and atherosclerosis.